John Drayton Wise, Chief Commercial Officer at INSMED Inc (INSM), sold 16,495 shares at $65.98 ($1.1M) on 2025-01-07, disclosed to the SEC on 2025-01-10.
Scheduled sale ($1.1M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.87 | 2,908 | $192K | 17.6% |
| 2 | $65.87 | 2,908 | $192K | 17.6% |
| 3 | $65.98 | 10,000 | $660K | 60.7% |
| 4 | $66.21 | 392 | $26K | 2.4% |
| 5 | $65.40 | 287 | $19K | 1.7% |
| Total | $65.94 avg | 16,495 |
| $1.1M |
| 100% |
| Filing → |
| INSM | SELL | 2024-05-15 | $259K | — | Filing → |
| INSM | SELL | 2024-01-11 | $107K | — | Filing → |
| INSM | SELL | 2024-01-05 | $34K | — | Filing → |